恶性肿瘤患者自体输血  

Autologous transfusion of malignancy tumor patients

作　　者：杨悦饶[1] 陈玲[1] 和苗[1] 马娜[1] 向睿[1] 王燕[1] 

机构地区：[1]昆明医学院第三附属医院云南省肿瘤医院输血科,昆明650118

出　　处：《临床血液学杂志（输血与检验）》2010年第2期207-209,共3页Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)

摘　　要：目的:探索恶性肿瘤患者自体输血的可行性。方法:分析自体输血和异体输血对择期手术恶性肿瘤患者的影响。结果:肿瘤患者自体输血较异体输血,输血反应发生率、感染率和输血费用低。结论:对恶性肿瘤患者实施自体输血是可行的,既可节约血源又减少输血反应的发生和疾病传播,而且不需要检测血型和交叉配血,减少患者经济负担。Objective：To investigate the feasibility of autologous transfusion of patients with malignancy tumor.Methods：The effects of autologous transfusion and homologous transfusion on malignancy tumor patients with optional operation were analyzed.Results：Patients received autologous transfusion has lower incidence of transfusion reactions,lower infection rate and lower fare,compared to patients received homologous transfusion.Conclusion：It is feasible to practice autologous transfusion in patients with malignant tumors,which could save the source of blood,decrease transfusion reactions and transfusion transmitted diseases,and need no blood group typing,cross matching and blood cost and reduce the financial burden of patients.

关 键 词：恶性肿瘤患者 自体输血 输血相关疾病 

分 类 号：R457.1[医药卫生—治疗学]